Gelonghui September 30th | chison medical technologies (688358.SH) announced its 2024 restricted stock incentive plan, intending to grant 593,000 restricted stocks to incentive recipients, accounting for approximately 0.53% of the company's total share capital of 112,124,537 shares at the time of the announcement of this incentive plan draft. Among them, the initial grant is 475,500 shares, accounting for about 0.42% of the company's total share capital of 112,124,537 shares at the time of the announcement of this incentive plan draft, with the initial grant portion accounting for 80.19% of the total equity granted this time; reserving 117,500 shares, accounting for approximately 0.10% of the company's total share capital of 112,124,537 shares at the time of the announcement of this incentive plan draft, and the reserved portion accounting for 19.81% of the total equity granted this time.